Drug Formulary Review Archives – April 1, 2008
April 1, 2008
View Issues
-
Medication therapy management definition can help achieve payment
Developing a widely accepted definition of medication therapy management (MTM) and its role in the pharmacist patient care continuum is important if pharmacists are to receive additional payment for providing such services. -
Diabetes project creates pharmacist-run program
El Rio Community Health Center's pharmacy-based diabetes management program has gotten a boost with a $250,000 grant from the Bank of America Foundation. -
Too many look-alike, sound-alike drug names
Nearly 3,200 pairs of U.S. approved generic and brand drug names look or sound enough alike that health care workers mix up the medications. That's the finding of new research from the United States Pharmacopeia (USP), which reviewed more than 26,000 records in two USP-associated medication error reporting programs for 2003-2006. -
Device prevents errors in compounding meds
A device tested at the University of Michigan Health System was 100% accurate in identifying the proper formulations of seven intravenous drugs. -
Pharmacists become clinical service providers
The American College of Clinical Pharmacy (ACCP) believes that within 20-30 years, most clinical pharmacy specialists will be board-certified specialists. -
News Briefs
Baxter Healthcare Corp. temporarily stopped manufacturing multiple-dose vials of heparin due to a spike in reports of serious allergic reactions and hypotension in patients receiving bolus doses of the drug. -
Drug Criteria & Outcomes: Tumor lysis syndrome: An ounce of prevention is worth a pound of cure
Tumor lysis syndrome (TLS) is a serious and life-threatening complication that is frequently seen following initiation of chemotherapy. -
Drug Criteria & Outcomes: An Awakening to Narcolepsy
Narcolepsy is a chronic neurological disorder, mistakenly thought to occur only rarely. However, approximately 5% of patients seen at the American Academy of Sleep Medicine in the United States have this disease and it is estimated that as many as one in 2,000 Americans have narcolepsy. -
Drug Criteria & Outcomes: New FDA Approvals
FDA recently announced these approvals: FDA approved Medtronic's Endeavor® Zotarolimus-Eluting Coronary Stent for use in treating patients with narrowed coronary arteries.